A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/1998
01/06/1998	CA2095128C Methanediphosphonate derivative, its manufacturing process and its pharmaceutical applications
01/06/1998	CA2084875C Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
01/06/1998	CA2033814C Inhibitor of the proliferation of herpesviruses and inhibitor of the recurrence of affections caused by their latent infection
01/06/1998	CA2029372C 1,2-benzisoxazole derivatives, processes for their preparation and pharmaceutical compositions containing them
01/06/1998	CA1339623C Lhrh antagonists
01/05/1998	CA2209581A1 Agent for prophylaxis and treatment of disturbance of visual function
01/02/1998	DE19627340A1 Arzneimittel Drug
01/02/1998	DE19626020A1 Synthetic siderophore compounds
01/02/1998	DE19625582A1 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen Involving use of flupirtine for the prophylaxis and treatment of diseases with a non-physiological high cell death rate
01/02/1998	DE19624426A1 Magnetic particle for transport of diagnostic or therapeutic agent
01/02/1998	DE19624291A1 Isoxazolo-diazepinone derivatives to relax smooth muscle,
01/02/1998	DE19624290A1 Pyrrolizine derivatives to lower lipid levels,
01/02/1998	DE19624282A1 Use of 5-(omega-amino-alkylamino)-isoxazole derivatives as 5-HT receptor antagonists
01/02/1998	CA2206752A1 Benzothiophene compounds, intermediates, processes, and methods of use
01/01/1998	CA2209205A1 Pharmaceutical composition for the treatment of leukemia containing 9-cis-retinoic acid-alpha-tocopherol ester
12/1997
12/31/1997	WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants
12/31/1997	WO1997049825A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus
12/31/1997	WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase
12/31/1997	WO1997049736A2 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
12/31/1997	WO1997049735A1 Nerve process growth modulators
12/31/1997	WO1997049710A1 Spiro-piperidine derivatives and their use as therapeutic agents
12/31/1997	WO1997049709A1 Androgen receptor modulator compounds and methods
12/31/1997	WO1997049708A1 Tricyclic benzazepine vasopressin antagonists
12/31/1997	WO1997049707A1 Tricyclic benzazepine vasopressin antagonists
12/31/1997	WO1997049704A1 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
12/31/1997	WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
12/31/1997	WO1997049700A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
12/31/1997	WO1997049699A1 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
12/31/1997	WO1997049692A1 1,2,4-benzothiadiazine derivatives, their preparation and use
12/31/1997	WO1997049690A1 A method for treating meniere's disease
12/31/1997	WO1997049689A1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
12/31/1997	WO1997049684A1 Factor vii-binding reagent
12/31/1997	WO1997049682A1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
12/31/1997	WO1997049680A1 Il-8 receptor antagonists
12/31/1997	WO1997049679A1 Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient
12/31/1997	WO1997049674A1 Matrix metalloproteinase inhibitors
12/31/1997	WO1997049673A1 Selective thrombin inhibitors
12/31/1997	WO1997049670A1 New synthetic catechol derivatives, method for production and use thereof
12/31/1997	WO1997049669A1 Compounds which can form complexes with metals
12/31/1997	WO1997049667A1 Inhibitors of oleamide hydrolase
12/31/1997	WO1997049662A1 Quinone bacterial inhibitors
12/31/1997	WO1997049433A1 Fluoro labelled anthracyclinone and anthracycline derivatives
12/31/1997	WO1997049428A1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
12/31/1997	WO1997049420A1 Lectin compositions and uses thereof
12/31/1997	WO1997049413A1 Ionic polymers as anti-infective agents
12/31/1997	WO1997049412A1 Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
12/31/1997	WO1997049411A1 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
12/31/1997	WO1997049410A1 Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
12/31/1997	WO1997049409A1 Chelating agents and their metal chelates for treating free radicals induced conditions
12/31/1997	WO1997049408A1 The use of growth factor modulating compounds
12/31/1997	WO1997049407A1 Progestogen-anti-progestogen regimens
12/31/1997	WO1997049406A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction
12/31/1997	WO1997049405A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative
12/31/1997	WO1997049404A1 Anticoagulant agents
12/31/1997	WO1997049403A1 Use of nipecotic acid or guvacine derivatives for the manufacture of a medicament for the treatment of postischemic neurodegenerative disorders
12/31/1997	WO1997049402A1 Sustained release sufentanil compositions
12/31/1997	WO1997049401A1 Use of fe (ii) chelators to treat and prevent vasospasm
12/31/1997	WO1997049400A1 Il-8 receptor antagonists
12/31/1997	WO1997049399A1 Il-8 receptor antagonists
12/31/1997	WO1997049398A1 Use of flupirtine to prevent cell damage by apoptosis and necrosis
12/31/1997	WO1997049396A1 Use of lofexidine in the manufacture of a medicament for treating attention deficit hyperactive disorder
12/31/1997	WO1997049395A1 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
12/31/1997	WO1997049394A2 Sold oral dosage forms of valsartan
12/31/1997	WO1997049393A1 Use of a tachykinin antagonist for the manufacture of a medicament for the treatment of emesis
12/31/1997	WO1997049391A1 Methods for providing safe local anesthesia
12/31/1997	WO1997049390A1 Reduction of cardiotoxicity of an antitumor agent using manganese compound
12/31/1997	WO1997049388A1 Remedies for renal diseases and organ-preserving agents
12/31/1997	WO1997049387A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
12/31/1997	WO1997049383A1 Antibacterial composition
12/31/1997	WO1997049382A1 Iontophoretic delivery devices for antagonists of glycoprotein iib/iiia
12/31/1997	WO1997049375A1 Cosmetic compositions
12/31/1997	WO1997049286A1 Il-8 receptor antagonists
12/31/1997	WO1997045528A3 Mammalian tolloid-like gene and protein
12/31/1997	WO1997045091A3 Sustained release oxycodone formulations with no fed/fast effect
12/31/1997	WO1997044454A3 Human phospholipase inhibitor
12/31/1997	WO1997044000A3 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
12/31/1997	WO1997038726A3 Hydrophobic carbomer complex compositions
12/31/1997	WO1997030159A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/31/1997	WO1997027179A3 Antiretroviral bases
12/31/1997	CN1169161A Attenuated viruses and method of making same
12/31/1997	CN1169145A Novel farnesyl tranfering enzyme inhibitor, prepn. method and medicinal composition thereof
12/31/1997	CN1169142A Compound for inhibition of gastric acid secretion
12/31/1997	CN1169137A Improved synthesis of cyclopropylacetylene
12/31/1997	CN1169116A Method for inhibiting environmental estrogens
12/31/1997	CN1169115A Liposomes containing a corticosteroid
12/31/1997	CN1169109A 稳定的油包水乳状液体系 Stable oil-in-water emulsion system
12/31/1997	CN1168891A Method for preparing chelate of antibiotic and complex metallic salt
12/31/1997	CN1168886A Process for production of amidinobenzofuran and amidionbenzothiophen derivatives and salt thereof
12/31/1997	CN1168885A Process for prodn. of amidinoindole derivatives and salts thereof
12/31/1997	CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia
12/31/1997	CN1168792A Matrix table allowing prolonged release of sodium salt of tianeptine after administration by oral route
12/31/1997	CN1036849C Method for prepn. of anti-viral compounds
12/31/1997	CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen
12/31/1997	CN1036835C Method for prepn. of multiple step combination type contraceptive
12/31/1997	CN1036834C Method for prepn. of contraceptive
12/31/1997	CN1036833C Method for prepn. of multiple step contraceptive
12/31/1997	CN1036832C Method for prepn. of injectable solution for treating bacterial infection
12/31/1997	CA2262765A1 Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
12/31/1997	CA2259344A1 Ionic polymers comprising an amino or ammonium group as anti-infective agents
12/31/1997	CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants

1 ... 6706 6707 6708 6709 6710 6711 6712 6713 6714 6715 6716 6717 6718 6719 6720 6721 6722 6723 6724 6725 6726 ... 7860